Larotrectinib efficacy and safety in TRK fusion cancer: An expanded clinical dataset showing consistency in an age and tumor agnostic approach Meeting Abstract
| Authors: | Blattmann, C.; Albert, C. M.; Kummar, S.; van Tilburg, C. M.; Dubois, S. G.; Geoerger, B.; Mascarenhas, L.; Federman, N.; Schilder, R. J.; Doz, F.; Berlin, J. D.; Oh, D. Y.; Bielack, S. S.; McDermott, R.; Tan, D. S.; Cruickshank, S.; Ku, N. C.; Cox, M. C.; Drilon, A.; Hong, D. S.; Lassen, U. N. |
| Abstract Title: | Larotrectinib efficacy and safety in TRK fusion cancer: An expanded clinical dataset showing consistency in an age and tumor agnostic approach |
| Meeting Title: | Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie |
| Journal Title: | Oncology Research and Treatment |
| Volume: | 42 |
| Issue: | Suppl. 4 |
| Meeting Dates: | 2019 Oct 11-14 |
| Meeting Location: | Berlin, Germany |
| ISSN: | 2296-5270 |
| Publisher: | S. Karger AG |
| Date Published: | 2019-10-01 |
| Start Page: | 27 |
| Language: | English |
| ACCESSION: | WOS:000568159600062 |
| PROVIDER: | wos |
| DOI: | 10.1159/000502425 |
| Notes: | "Annual Meeting of the German, Austrian and Swiss Societies for Hematology and Medical Oncology" -- Meeting Abstract: V108 -- Source: Wos |
